Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.
Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.
Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…Generalized dystonia and spasticity: The fault in the mitochondria
Objective: To analyze the pattern of movement disorder in a child with mitochondrial respiratory chain disorder Background: Secondary movement disorders are often a clue to…Differences of social and clinical factors related with distribution of DBS in Mexican PD population
Objective: To identify which social and clinical factors are related to disparities between the distribution of DBS in Mexican PD population Background: Deep Brain stimulation…Machine Learning Prediction of Gait Dysfunction from DTI Multi-Spectral Diffusion Weighted Imaging ROIs
Objective: To compare the performance of various machine learning techniques, including LDA, k-NN, SVM, MLP, Long Short-Term Memory (LSTM), Gradient Boosting Machines (GBM), Random Forest,…Olfactory and taste function in early Parkinson’s disease with mild cognitive impairment
Objective: The purpose of this study was to compare olfactory and taste function between early drug-naive Idiopathic Parkinson's disease (IPD) patients with or without mild…Clinical toolkits to improve conversations about Parkinson’s dementia
Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease
Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…White matter lesion burden is associated with poorer clinical and driving outcomes in mild Parkinson’s disease
Objective: To determine association of brain white matter microvascular lesion burden with cognition, motor function, and driving in mild Parkinson’s disease (PD). Background: Brain white…Muscle functions on the movement timings and inhibition in Parkinson’s disease.
Objective: To assess the role of muscle strength, muscle tone and reflexes on the movement timings and inhibitory control in the subjects of Parkinson’s disease…
- « Previous Page
- 1
- …
- 490
- 491
- 492
- 493
- 494
- …
- 1734
- Next Page »